1. Lyophilized nanosuspension comprising drug and a steric stabilizer which is a solid at room temperature.2. Lyophilized nanosuspension according to claim. 1, wherein the steric stabilizer is a crystalline solid at room temperature.3. Lyophilized nanosuspension according to claim. 1, wherein the steric stabilizer is an amorphous solid at room temperature.4. Lyophilized nanosuspension according to claim. 1, wherein the steric stabilizer is selected from a polymer or surfactant veschestva.5. Lyophilized nanosuspension according to claim. 4, wherein the steric stabilizer is a surfactant veschestvo.6. Lyophilized nanosuspension according to claim. 5, wherein the surfactant is a poloksamer.7. Lyophilized nanosuspension according to claim. 6, wherein the poloxamer is poloxamer 338.8. Lyophilized nanosuspension according to claim. 1 further comprising krioprotektor.9. Lyophilized nanosuspension according to claim. 8, wherein the cryoprotectant is selected from polyvinylpyrrolidone, sucrose, tregalozy.10. Lyophilized nanosuspension according to claim. 9, wherein the cryoprotectant is a polivinilpirrolidon.11. Lyophilized nanosuspension according to claim. 1-10, wherein the drug is sparingly soluble, very sparingly soluble or almost insoluble drugs sredstvom.12. Lyophilized nanosuspension according to claim. 1-10, wherein the medicament is 4 - [[4 - [[4- (2-cyanoethenyl) -2,6-dimethylphenyl] amino] -2-pyrimidinyl] amino] benzonitrile, or a stereoisomeric form thereof or a pharmaceutically sol.13 acceptable. L Lyophilized nanosuspension according to claim. 1 further comprising krioprotektor.9. Lyophilized nanosuspension according to claim. 8, wherein the cryoprotectant is selected from polyvinylpyrrolidone, sucrose, tregalozy.10. Lyophilized nanosuspension according to claim. 9, wherein the cryoprotectant is a polivinilpirrolidon.11. Lyophilized nanosuspension according to claim. 1-10, wherein the drug is sparingly soluble, very sparingly soluble or almost insoluble drugs sr
